Use of medication during pregnancy
102 results
1 - 100
Use of medication during pregnancy - Chronic diseases and pregnancy
Psychosocial and medication interventions to stop or reduce alcohol consumption during pregnancy- Fertility counselling
- Antenatal clinics: care and examinations
Antiviral medication exposure safe in first trimester of pregnancy- Maternal triptan use during pregnancy is not associated with risk of attention-deficit/hyperactivity disorder in offspring
- Antenatal clinics and specialist care: consultations, referrals, treatment guidelines
- Mental disorders during pregnancy
- Safety of nitrofurantoin during pregnancy
- Ondansetron use in pregnancy associated with small increased risk of oral clefts
- No increased risk of ASD, ADHD, or SGA with first-trimester antidepressant use
- Medical treatments for idiopathic thrombocytopenic purpura during pregnancy: Cochrane systematic review
- Oxytocin antagonists for assisted reproduction
- Zolpidem associated with adverse pregnancy outcomes
- Traveller's infection prophylaxis
- Skin problems during pregnancy
- Periconception antibiotics associated with birth defects
- Safe use of non-steroidal anti-inflammatory drugs (NSAIDs)
- Pharmacological interventions for promoting smoking cessation during pregnancy
- Hypnosis for pain management during labour and childbirth
- SSRI use during pregnancy may increase risk of speech/language disorders in offspring
- Gastro-oesophageal reflux disease
- Overweight in pregnancy
- Perioperative pharmacological interventions for fetal immobilisation during fetal surgery and invasive procedures
- Prenatal exposure to pregabalin associated with major birth defects
- Imaging for the exclusion of pulmonary embolism in pregnancy
- Trichinellosis
- Buprenorphine combined with naloxone is safe and effective for opioid use disorder in pregnancy
- Migraine
- Porphyrias
- Fetal biometry for guiding the medical management of women with gestational diabetes mellitus for improving maternal and perinatal health
- Elevated blood pressure in pregnancy (gestational hypertension, pre-eclampsia)
- Nausea and vomiting
- In utero SSRI associated with adverse perinatal events
- Similar risk of major malformations in infants of asthmatic women with alternate treatment regimens
- Progestogen for preventing miscarriage in women with recurrent miscarriage of unclear etiology
- Screening and subsequent management for thyroid dysfunction pre‐pregnancy and during pregnancy for improving maternal and infant health
- Rheumatoid arthritis
- Glaucoma
- Interventions to increase adherence to medications for tobacco dependence
- Treatment for epilepsy in pregnancy: neurodevelopmental outcomes in the child
- Drug treatment for hypertension
- Maternal gestational diabetes before 26 weeks' associated with risk of ASD
- Noninvasive bioelectronic treatment reduces opioid use among patients after cesarean delivery
- Thrombocytosis
- Insulin for the treatment of women with gestational diabetes
- 17-OHPC may not reduce recurrent preterm birth or decrease neonatal morbidity
- Care prior to and during subsequent pregnancies following stillbirth for improving outcomes
- Micronutrient supplementation in pregnant women with HIV infection
- Interventions (other than pharmacological, psychosocial or psychological) for treating antenatal depression
- Metformin for women who are overweight or obese during pregnancy for improving maternal and infant outcomes
- Growth hormone for in vitro fertilisation (IVF)
- Probiotics for preventing gestational diabetes
- Myasthenia gravis
- Pharmacological treatment of depression
- Common antiepileptic drugs in pregnancy in women with epilepsy: Cochrane systematic review
- Exposure to tuberculous infection
- Misoprostol for intrauterine device placement
- Individualised gonadotropin dose selection using markers of ovarian reserve for women undergoing in vitro fertilisation plus intracytoplasmic sperm injection (IVF/ICSI)
- Benign gynaecological lesions and tumours
- Antibiotics for treating gonorrhoea in pregnancy
- Non‐pharmacological care for opioid withdrawal in newborns
- Infertility
- Disulfiram for the treatment of cocaine dependence
- Examination and treatment of a rape victim
- Providing care for an alcohol or drug abuser
- Capsaicin for non‐allergic rhinitis
- Perioperative systemic nonsteroidal anti‐inflammatory drugs (NSAIDs) in women undergoing breast surgery
- Interventions for the prevention of OHSS in ART cycles: an overview of Cochrane reviews
- Hereditary angioedema (HAE) and ACE inhibitor-induced angioedema
- Selective oestrogen receptor modulators (SERMs) for endometriosis
- Chronic heart failure
- Syncope: causes and investigations
- Digital tracking, provider decision support systems, and targeted client communication via mobile devices to improve primary health care
- A crying infant
- Mechanical methods for induction of labour
- Antiretroviral therapy (ART) for treating HIV infection in ART-eligible pregnant women: Cochrane systematic review
- Lyme borreliosis (LB)
- Prevention of venous thromboembolism
- Guidelines for antimicrobial therapy
- Abnormal menstrual bleeding
- Interventions for cutaneous disease in systemic lupus erythematosus